JMC|Insilico Medicine nominates novel AI-driven PHD inhibitor targeting anemia
Clinical stage generative artificial intelligence (AI)-driven biotechnology company InSilico Medicine (“InSilico”), today announced that the Journal of Medicinal Chemistry, an ACS Publications journal focusing on...